手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 医学研究 Volume 5, Issue 15. 2023.
HP 感染与冠状动脉粥样硬化性心血管疾病关系的研究进展
作者 : 张 晨1, 严金 龙2
DOI: 10.12361/2661-3603-05-15-141457
全部来源
获取全文
摘要 / Abstract
摘要：幽门螺杆菌(HelicobacterPylori，HP)感染是我国常见的慢性感染性疾病.且它的高感染率已渐渐成为一个在全球范围性受瞩目的医学问 题。冠状动脉粥样硬化性心脏病是指由于冠状动脉粥样硬化使冠状动脉管腔狭窄或闭塞导致心肌缺血、缺氧或坏死从而引发的心脏病，统 称为冠状动脉性心脏病或冠状动脉疾病，简称冠心病。近几年来有大量研究表明心血管疾病的发生发展与 HP 感染有关，本篇综述旨在说 明 HP 与冠心病的关系，以及 HP 可能通过影响血脂代谢、炎症反应、血管内皮损伤、血栓形成以及其它肠外疾病等因素，促进动脉粥样硬 化的发生与发展。
关键词 / Keywords
关键词：幽门螺杆菌；冠状动脉粥样硬化性心血管疾病；血脂代谢；炎症反应；血管内皮损伤；血栓形成；血浆致动脉粥样硬化指数
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1] HUY，ZHUY，LUNH．Primary Antibiotic Resistance Of
  • Helicobacter Pylori in China[J]. DigDisSci，2020，62(5):1146-1154
  • [2] Helicobacter Pylori in fected subjects [J].Atherosclerosis,2008,
  • 196(1);270-27
  • [3] Farsak,Yildirira,Akyny,etal. Detection of Chlamy diaPneumoniae
  • and Helicobacter Pylori DNA in human atheros clerotic Plaques by
  • PCR[J]. Journal of Clinical Microbiology,2000,38(12);4408-4411.
  • [4] JamkhandePG,GattaniSG,FarhatSA. Helicobacter Pylori
  • cardiovascular comPlications ; amechanism based review on role of
  • Helicobacter Pylori in cardiovascular diseases[J]. IntegrMedRes,2016,5
  • (4); 244-249.
  • [5] 黄赞鸿,刘昱,林英奎. 颈动脉粥样硬化狭窄程度与幽门螺杆
  • 菌感染的关系[J]. 中国医学创新, 2021,18(18):115-119.
  • [6] 顿国栋. 幽门螺杆菌感染与冠心病患者冠脉病变程度及临
  • 床预后的关系[J]. 中国保健营养,2017,27(8):44-45.
  • [7] Pasceriv,Pattig,etal.Virulent strains of Helicobacter Pylori and
  • vascular diseases; ameta-analysis [J] American Heart Journal,2015,151
  • (6);1215-1222.
  • [8]Rasmiy,Rouhrazih,Khayat-Ishale,etal.Association ofendotheliald
  • -ys function and cytotoxin-associated geneA-Positive Helicobacter
  • Pylori inPatients with cardiacsy indrome X[J].Biomedical Journal,2016,
  • 39(5);339-345.
  • [9] Tamergs,Tengizi,Ercane,etal.Helicobacter Pylorisero-Positivity
  • inPatients with acute coronary syndromes[J].DigestiveDiseasesandScienc
  • -es,2016,54(6);1253-1256.
  • [10] Laurila A, Bloigu A, Näyhä S, et al. Association of Helicobacter
  • pylori infection with elevated serum lipids. Atherosclerosis, 1999,
  • 142(1):207-210.
  • [11] Li Du,Liu JH,Jin C,et al. Association between Helicobacter
  • pylori infection and carotid atherosclerosis in Chinese adults.
  • Atherosclerosis Plus, 2021(44):25-30.
  • [12] Ninomiya R, Kubo S, Baba T, et al. Inhibition of low-density
  • lipoprotein uptake by Helicobacter pylori virulence factor CagA.
  • Biochem Biophys Res Commun, 2021(556):192-198.
  • [13]Tobinnp,Henehangt,Murphyrp,etal.Helicobacter Pylor-iinduced
  • inhibition of vasculare ndothelial cell functions ;arolefor VacA-dePend
  • entnitricoxi dereduction [J].AmJ Physiol HeartCircPhysiol,2018,295(4) ;
  • H1403-H1413
  • [14] Wang L, Tan RZ, Chen Y, et al. CagA promotes proliferation
  • andsecretion of extracellular matrix by inhibiting signaling pathway of
  • apoptosis in rat glomerular mesangial cells. Ren Fail, 2016,
  • 38(3):458-464.
  • [15] Öztekin M, Y1lmaz B, Ağagündüz D, et al. Overview of
  • Helicobacterpylori Infection: Clinical Features, Treatment, and
  • Nutritional Aspects. Diseases, 2021, 9(4):66.
  • [16] Aimasso U, D'onofrio V, D'eusebio C, et al. Helicobacter
  • pylori andnutrition: a bidirectional communication. Minerva
  • Gastroenterol Dietol, 2019, 65(2):116-129.
  • [17] Vitale G, Barbaro F, Ianiro G, et al. Nutritional aspects of
  • Helicobacter pylori infection. Minerva Gastroenterologica E Dietologica,
  • 2011, 57(4):369.
  • [18] Fernández-Macías JC,Ochoa-Martínez AC, Varela-Silva
  • JA, P é rez-Maldonado IN. Atherogenic Index of Plasma: Novel
  • Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019
  • Jul;50(5):285-294.
  • [19] Vasan RS. Biomarkers of cardiovascular disease: molecular
  • basis and practical considerations. Circulation 2006;113:2335-2362.
  • [20] Yusuf S,Hawken S,Ounpuu S, et al Obesity and the risk of
  • myocardial infarction in 27,000 participants from 52 countries: a
  • case-control study. Lancet (London, England) 2005;366:1640-1649
  • [21] Edwards MK, Blaha MJ, Loprinzi PD. Atherogenic Index of
  • Plasma and Triglyceride/High-Density Lipoprotein Cholesterol Ratio
  • Predict Mortality Risk Better Than Individual Cholesterol Risk Factors,
  • Among an Older Adult Population. Mayo Clinic Proc 2017;92: 680-681.
  • [22] Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva
  • JA, P é rez-Maldonado IN. Atherogenic Index of Plasma: Novel
  • Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019
  • Jul;50(5):285-294.
  • [23] Dobiasova M. AIP – atherogenic index of plasma as a
  • significant predictor of cardiovascular risk: from research to practice.
  • Vnitr Lek 2016;52:64e71.
  • [24] Dobiasova M, Frohlich J. The plasma parameter log
  • (TG/HDL-C) as an atherogenic index: correlation with lipoprotein
  • particle size and esterification rate in apoB-lipoprotein-depleted plasma
  • (FER(HDL)).Clin Biochem 2001;34(7):583-588.
  • [25] Yildiz G, Duman A, Aydin H, et al Evaluation of association
  • between atherogenic index of plasma and intima-media thickness of the
  • carotid artery for subclinic atherosclerosis in patients on maintenance
  • hemodialysis. Hemodial Int 2013;17:397-405.
  • 作者简介：张晨，男，硕士研究生在读，研究方向：心血管疾
  • 病
  • 通讯作者：严金龙，男性，主任医师，副教授，研究方向：心
  • 血管疾病 ，E-mail：214289027@qq.com
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号